A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
about
Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosaCeftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infectionsCommunity-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study.Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department usersExtended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceRectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in MadagascarDramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008Influence of a probiotic mixture on antibiotic induced microbiota disturbances.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study.National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases2013 WSES guidelines for management of intra-abdominal infections.The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring systemAntibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series.Value of an aggregate index in describing the impact of trends in antimicrobial resistance for Escherichia coli.Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital.Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae.Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies.Epidemiology and characteristics of urinary tract infections in children and adolescents.Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant EnterobacteriaceaePreventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.Extended-Spectrum β-Lactamases and/or Carbapenemases-Producing Enterobacteriaceae Isolated from Retail Chicken Meat in Zagazig, Egypt.Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012Extended spectrum ß-lactamase-producing Escherichia coli in neonatal care unitAntimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in TaiwanPretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France.High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteriaDetection of extended-spectrum β-lactamase and Klebsiella pneumoniae Carbapenemase genes directly from blood cultures by use of a nucleic acid microarray
P2860
Q24612271-10B1648B-D029-4FA5-B993-69ADF036D644Q28069563-A7F22885-C8FA-48CA-8E8D-F4F8E97A7FD6Q30358381-C1A59C17-F959-48CD-9FA9-326640ADAB7BQ30828046-BA02D0EC-BA50-4F97-AB09-6F60431E49D0Q31047716-65D9636D-3398-4FF8-84BB-33B02CC61975Q33606193-2C597D9C-FD16-4C6A-9C4E-14A79224BAE5Q33614205-70428576-978F-48D2-ABE9-22B8DC0754CFQ33640559-2C7E62BC-9876-43FB-AC52-8BD8E6219547Q33987808-9713F7A0-7C4B-463D-9994-A1628CBADED2Q34027016-5E1BF90D-FFE1-468C-9876-DDFD0699B664Q34137444-E49367FF-FC57-428B-BD80-7DDF81E96E79Q34150900-ADE3B588-CA2E-49DC-897D-A5F7C3C4E41DQ34269727-BBB485E0-46D3-4902-BB6A-75310D1F1349Q34309458-769D2010-118B-44CF-B8B2-83E7B69B63A8Q34321150-FA51D6F9-ED30-4379-B291-4E235804F5E0Q34654002-B33796C8-06FD-47DA-A0FC-375990172BF0Q34678004-837D94EF-FC2A-4C37-9C82-B62AE8C6F60DQ34920553-803DFDFA-7356-4E2A-83DF-3C9FA9EADBEAQ34932937-780C6E91-2C4E-4496-90EF-E38E12FBA26BQ35065834-AA55282F-A695-4572-B21E-C68E219CC778Q35065875-AFA0695A-BA7D-4701-92C5-30BD0421643EQ35115778-4F458306-F411-47E1-BFB6-997076ACA1F2Q35158122-784CC782-2537-4EAB-B9CE-63CDA41288D3Q35168939-2742C3AE-F819-482B-AFE0-1396246A9485Q35207767-AAABD4E8-0843-434D-A050-B6FA57F96DADQ35551647-81D97B2C-C473-4B19-AB1F-5CFAC598C1D3Q35552650-0F4252B6-6D44-44EA-B2E1-5175E9104A61Q35567738-BF2D1510-540A-46E4-97F6-6A47203D12A8Q35644344-292C1469-D60B-4FB2-B925-C3F816B265E2Q35689050-E2B5969A-40E5-4642-827F-287DE3758B46Q35700982-1D9CBB18-4C92-42A5-9DF7-933D98BE95D1Q35738292-BD5D22EF-8653-490F-A139-A91D4EA6FE99Q35748727-CB9633BB-0360-4BEE-85DA-10F66E93F402Q35779627-41B7D8AA-45BC-4B2F-85CB-249030AF588CQ35804904-5C524E87-34A2-4A5C-91C9-413DA90F2FBAQ35859801-9D419EF4-3D43-4EC7-BD53-2F4A2B28BC16Q35979859-6611347C-A1D6-4439-8816-7AC1E802D63CQ35993023-2D992D80-131A-43BB-9071-189DD0274A95Q36028111-6366F2B8-7A5F-4E74-94F0-AC59CB986C20Q36172336-029A6EF1-8621-4B15-8752-44748B951C77
P2860
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A multinational survey of risk ...... e in nonhospitalized patients.
@en
A multinational survey of risk ...... e in nonhospitalized patients.
@nl
type
label
A multinational survey of risk ...... e in nonhospitalized patients.
@en
A multinational survey of risk ...... e in nonhospitalized patients.
@nl
prefLabel
A multinational survey of risk ...... e in nonhospitalized patients.
@en
A multinational survey of risk ...... e in nonhospitalized patients.
@nl
P2093
P50
P356
P1476
A multinational survey of risk ...... e in nonhospitalized patients.
@en
P2093
Claudine Quentin
David M Livermore
Hande Arslan
Javier Garau
Johann D D Pitout
Ozlem K Azap
Ronen Ben-Ami
Yehuda Carmeli
P304
P356
10.1086/604713
P407
P577
2009-09-01T00:00:00Z